Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 128 citing articles:

Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
Benjamin Schwarz, Lokesh Sharma, Lydia M. Roberts, et al.
The Journal of Immunology (2020) Vol. 206, Iss. 2, pp. 329-334
Open Access | Times Cited: 163
The Uniqueness of Tryptophan in Biology: Properties, Metabolism, Interactions and Localization in Proteins
Sailen Barik
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8776-8776
Open Access | Times Cited: 153
Metabolomics study of COVID-19 patients in four different clinical stages
Alberto Valdés, Lorena Ortega Moreno, Silvia Rojo‐Rello, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 86
Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets
Zhiqiang Pang, Guangyan Zhou, Jasmine Chong, et al.
Metabolites (2021) Vol. 11, Iss. 1, pp. 44-44
Open Access | Times Cited: 97
Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses
Nathan G. Lawler, Nicola Gray, Torben Kimhofer, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 5, pp. 2796-2811
Closed Access | Times Cited: 95
Metabolomics in infectious diseases and drug discovery
Vivian Tounta, Yi Liu, Ashleigh Cheyne, et al.
Molecular Omics (2021) Vol. 17, Iss. 3, pp. 376-393
Open Access | Times Cited: 94
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, et al.
Metabolomics (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 91
Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients
Judith Marín‐Corral, Jose Rodríguez‐Morató, Àlex Gomez‐Gómez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4794-4794
Open Access | Times Cited: 76
Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Jon Hazeldine, Janet M. Lord
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73
Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis
Laura Ansone, Monta Brīvība, Ivars Silamiķelis, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 73
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 67
Metabolomics in the Diagnosis and Prognosis of COVID-19
Mohammad R. Hasan, Mohammed Suleiman, Andrés Pérez‐López
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 66
Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19
Yamilé López‐Hernández, Joel Monárrez‐Espino, Ana-Sofía Herrera-van Oostdam, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 59
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
Abbas F. Almulla, Thitiporn Supasitthumrong, Chavit Tunvirachaisakul, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 59
Immunosenescence and inflamm-ageing in COVID-19
Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Mohsen Ghiasi, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101818-101818
Open Access | Times Cited: 39
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Chiara Bruzzone, Ricardo Conde, Nieves Embade, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 28
Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation
Yafeng Li, Jessica S. Hook, Ding Qing, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers
A. D. Wilson, Lisa Beth Forse
Sensors (2023) Vol. 23, Iss. 6, pp. 2887-2887
Open Access | Times Cited: 22
Neural mechanisms of parasite-induced summiting behavior in ‘zombie’ Drosophila
Carolyn Elya, Danylo Lavrentovich, Emily Lee, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 22
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19
Angelo D’Alessandro, Tiffany Thomas, Imo J. Akpan, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2293-2293
Open Access | Times Cited: 45
The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders
Upasana Parthasarathy, Roberta Martinelli, Elisabeth H. Vollmann, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114847-114847
Open Access | Times Cited: 45
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows
Michele Mussap, Vassilios Fanos
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 12, pp. 1891-1905
Open Access | Times Cited: 43
Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4611-4627
Open Access | Times Cited: 34
Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity
Ali Rahnavard, Brendan T. Mann, Abhigya Giri, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top